Akasi Pharma is focused on non-opioid therapeutics for diabetic peripheral neuropathic pain. Their drugs target somatostatin receptor 4, aiming to reduce neuronal pain safely and effectively, offering an innovative alternative to conventional treatments and improving quality of life for patients with chronic neuropathic conditions.